Why Every Cancer Patient Deserves Access to Better Options with Dr. Selin Kurnaz, co-founder and CEO of Massive Bio

What if every cancer patient could have the information and technology needed to find the right clinical trial or treatment option, regardless of where they live or what they can afford? In this episode, Dr. Selin Kurnaz, co-founder and CEO of Massive Bio, shares how a personal family experience with cancer prompted her to leave a successful career in transactions and build a company dedicated to improving cancer care. She describes Massive Bio’s mission to empower patients to take an active role in their care by making clinical trials and treatment options more accessible. Kurnaz explains how AI agents, conversational technology, and partnerships with specialized technology companies allow Massive Bio to create a scalable, end-to-end cancer patient journey. Looking ahead, she envisions Massive Bio becoming both a global access point for cancer patients and a real-world data infrastructure that helps pharmaceutical companies develop better, more personalized medicines. Tune in to hear Dr. Selin Kurnaz discuss the future of AI-powered cancer care, patient empowerment, and the role of real-world data in developing better treatments! Resources: Connect with and follow Dr. Selin Kurnaz on LinkedIn. Follow Massive Bio on LinkedIn and X and explore their website!